Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis

被引:26
|
作者
Lowes, Linda Pax [1 ]
Alfano, Lindsay [1 ]
Viollet, Laurence [1 ]
Rosales, Xiomara Quintero [1 ,2 ]
Sahenk, Zarife [1 ,2 ]
Kaspar, Brian K. [1 ,2 ]
Clark, K. Reed [1 ]
Flanigan, Kevin M. [1 ,2 ]
Mendell, Jerry R. [1 ,2 ]
McDermott, Michael P. [3 ]
机构
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Dept Pediat & Neurol, Columbus, OH 43210 USA
[3] Univ Rochester, Sch Med & Dent, Rochester, NY USA
关键词
functional outcomes; maximum voluntary isometric contraction testing; sporadic inclusion-body myositis; strength; prognosis; surrogate measures; DUCHENNE MUSCULAR-DYSTROPHY; RANDOMIZED PILOT TRIAL; CORTICOSTEROID TREATMENT; NATURAL-HISTORY; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; PREDNISONE; PLACEBO; DISEASE; PROGRESSION;
D O I
10.1002/mus.22321
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: In this study we address the challenging issue of potential use of muscle strength to predict function in clinical trials. This has immediate relevance to translational studies that attempt to improve quadriceps strength in sporadic inclusion-body myositis (sIBM). Methods: Maximum voluntary isometric contraction testing as a measure of muscle strength and a battery of functional outcomes were tested in 85 ambulatory subjects with sIBM. Results: Marked quadriceps weakness was noted in all patients. Strength was correlated with distance walked at 2 and 6 minutes. Additional correlations were found with time to get up from a chair, climb stairs, and step up on curbs. Conclusions: Quadriceps (knee extensor) strength correlated with performance in this large cohort of sIBM subjects, which demonstrated its potential to predict function in this disease. These data provide initial support for use of muscle strength as a surrogate for function, although validation in a clinical trial is required. Muscle Nerve, 2012
引用
收藏
页码:163 / 168
页数:6
相关论文
共 50 条
  • [41] Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers
    Anna Nogalska
    Carla D’Agostino
    W. King Engel
    William L. Klein
    Valerie Askanas
    Acta Neuropathologica, 2010, 120 : 661 - 666
  • [42] Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers
    Nogalska, Anna
    D'Agostino, Carla
    Engel, W. King
    Klein, William L.
    Askanas, Valerie
    ACTA NEUROPATHOLOGICA, 2010, 120 (05) : 661 - 666
  • [43] Treatment and prevention of the amyloidoses - Can the lessons learned be applied to sporadic inclusion-body myositis?
    Buxbaum, JN
    NEUROLOGY, 2006, 66 : S110 - S113
  • [44] MOLECULAR MIMICRY BETWEEN CELLULAR PHENOTYPES OF SPORADIC INCLUSION-BODY MYOSITIS, HEREDITARY INCLUSION-BODY MYOPATHY, ALZHEIMERS-DISEASE, AND PRION DISEASES
    ASKANAS, V
    ENGEL, WK
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 282 - 282
  • [45] Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers
    Nogalska, Anna
    D'Agostino, Carla
    Engel, W. King
    Askanas, Valerie
    NEUROSCIENCE LETTERS, 2011, 503 (03) : 229 - 233
  • [46] Clinical features of knee osteoarthritis in patients with sporadic inclusion body myositis
    Sugie, K.
    Eura, N.
    Sugie, M.
    Shiota, T.
    Iwasa, N.
    Shinmyo, N.
    Kawahara, M.
    Juo, K.
    Horikawa, H.
    Ueno, S.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S202 - S202
  • [47] Expression of granulysin in polymyositis and inclusion-body myositis
    Ikezoe, K.
    Ohshima, S.
    Osoegawa, M.
    Tanaka, M.
    Ogawa, K.
    Nagata, K.
    Kira, J-i
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (10): : 1187 - 1190
  • [48] Inclusion-body myositis associated with systemic sclerosis
    Bielsa, Silvia
    Belen Madronero, Ana
    Maria Grau, Josep
    Manuel Porcel, Jose
    MEDICINA CLINICA, 2007, 128 (07): : 278 - 278
  • [49] INCLUSION-BODY MYOSITIS PRESENTING WITH FACIAL DIPLEGIA
    Ghosh, Partha S.
    Laughlin, Ruple S.
    Engel, Andrew G.
    MUSCLE & NERVE, 2014, 49 (02) : 287 - 289
  • [50] The current status of treatment for inclusion-body myositis
    Griggs, RC
    NEUROLOGY, 2006, 66 : S30 - S32